[1]
R. Valenzuela, “Pilot Study on Evaluating Multiparametric MRI (mp-MRI) Including Contrast-Enhanced Susceptibility Imaging (CE-SWI) in Predicting Pathology Treatment Response in Rhabdomyosarcoma”, J Radiol Oncol, vol. 9, no. 3, pp. 062–074, Nov. 2025.